R. Saꢀnchez-Obregoꢀn et al. / Tetrahedron 63 (2007) 10521–10527
10525
0.88 (s, 9H), 1.21 (d, 3H, J 6.9), 1.46 (s, 9H), 2.40 (s, 3H),
2.69–2.98 (m, 2H), 4.06–4.26 (br m, 2H), 4.69 (br d, 1H),
7.30 and 7.56 (AA0BB0 system, 4H); (minor rotamer):
d 0.17 (s, 3H), 0.26 (s, 3H), 0.95 (s, 9H), 1.13 (d, 3H, J 6.9),
1.41 (s, 9H), 2.41 (s, 3H), 2.69–2.98 (m, 2H), 4.06–4.26 (br
m, 2H), 4.69 (br d, 1H), 7.32 and 7.51 (AA0BB0 system, 4H);
13C NMR (CDCl3, 75 MHz) (major rotamer): d ꢀ4.8, ꢀ4.3,
17.9, 18.5, 21.4, 25.8, 28.4, 48.3, 63.6, 70.3, 79.4, 123.9,
129.9, 140.9, 141.4, 155.6; (minor rotamer): d ꢀ4.8, ꢀ4.2,
17.9, 18.2, 21.4, 26.0, 28.4, 50.5, 63.8, 69.1, 79.4, 123.9,
130.0, 140.9, 141.4, 155.3. Anal. Calcd for C22H39NO4SSi:
C, 59.82; H, 8.90; N, 3.17. Found: C, 59.69; H, 8.98; N, 3.03.
anhydride (3.5 mL, 25.2 mmol, 10.5 equiv) were added.
The solution was allowed to reach room temperature and
stirred for 22 h. Then 60 mL of 10% NaHCO3 was added
and the resulting mixture was vigorously stirred for 20 h.
The mixture was extracted with Et2O (4ꢂ50 mL). The or-
ganic phase was separated, washed with 5% HCl (50 mL),
saturated NaHCO3 (2ꢂ50 mL), brine (50 mL), dried, and
concentrated. The product was purified by column chroma-
tography (hexane–ethyl acetate 85:15) to produce 0.946 g
(81%) of 6b as a colorless oil; [a]D ꢀ45.3 (c 1.0, CHCl3);
IR (CHCl3) nmax: 3500, 2956, 2860, 1704, 1675, 1468,
1367, 1296, 1163, 1118 cmꢀ1; 1H NMR (CDCl3, 300 MHz):
d 0.06 (s, 3H), 0.09 (s, 3H), 0.83 (d, 6H, J 6.3), 0.90 (s, 9H),
1.30–1.80 (m, 3H), 1.53 (s, 9H), 2.33 (s, 3H), 3.35 (br s, 2H),
3.54–3.80 (m, 2H), 4.43 (br t, 1H. J 9.6), 7.12 and 7.38
(AA0BB0 system, 4H); 13C NMR (CDCl3, 75 MHz):
d ꢀ4.6, ꢀ4.2, 18.1, 21.1, 21.3, 23.5, 24.7, 25.9, 28.1, 38.2,
58.8, 63.3, 73.6, 82.3, 129.3, 129.6, 135.5, 138.2, 158.1.
3.1.4. (2R,3S,Rs) tert-Butyl-2-(tert-butyldimethylsilyl-
oxy)-5-methyl-1-[(4-methylphenyl)sulfinyl]hexan-3-yl-
carbamate (5b). Following the same procedure used for the
preparation of 4a, and starting from 1.011 g (2.74 mmol) of
3b,17c 1.225 g (93%) of 5b was obtained. The product was
purified by column chromatography (hexane–ethyl acetate
85:15), mp 81–82 ꢁC (CH2Cl2–hexane); [a]D +98.4 (c 1.0,
CHCl3); IR (CHCl3) nmax: 3446, 1701, 1499, 1367,
3.1.7. (2S,3R) tert-Butyl-3-(tert-butyldimethylsilyloxy)-4-
hydroxybutan-2-yl-[(4-methylphenyl)sulfenyl]carba-
mate (7a). To a cooled solution of 5a (0.93 g, 2.1 mmol,
1 equiv) in 30 mL of dry acetonitrile, sym-collidine
(0.83 mL, 6.3 mmol, 3 equiv) and trifluoroacetic anhydride
(1.48 mL, 10.5 mmol, 5 equiv) were added. The solution
was allowed to reach room temperature and stirred for 7
days. Then 50 mL of 10% NaHCO3 was added and the
resulting mixture was vigorously stirred for 48 h. After the
addition of water (50 mL), the mixture was extracted with
Et2O (4ꢂ50 mL). The organic phase was separated, washed
with 5% HCl (50 mL), saturated NaHCO3 (50 mL), brine
(50 mL), dried, and evaporated. The product was purified
by column chromatography (hexane–ethyl acetate 8:2) to
produce 0.232 g (25%) of 7a as colorless oil; [a]D ꢀ77.6
(c 1.0, CHCl3); IR (CHCl3) nmax: 3478, 2930, 2858, 1702,
1
1166 cmꢀ1; H NMR (CDCl3, 300 MHz): d 0.10 (s, 6H),
0.87 (s, 9H), 0.95 (d, 6H, J 6.3), 1.20–1.75 (m, 3H), 1.45
(s, 9H), 2.39 (s, 3H), 2.74 (dd, 1H, J 3.0 and 12.9), 2.91 (dd,
1H, J 10.2 and 12.9), 4.05–4.20 (m, 2H), 4.62 (br d, 1H, J
9.6), 7.28 and 7.57 (AA0BB0 system, 4H); 13C NMR (CDCl3,
75 MHz): d ꢀ4.7, ꢀ4.2, 17.9, 21.3, 22.1, 23.2, 24.9, 25.8,
28.4, 41.9, 50.8, 63.9, 69.8, 79.3, 123.9, 129.8, 141.1,
141.2, 156.0.
3.1.5. (2S,3S) tert-Butyl-3-(tert-butyldimethylsilyloxy)-4-
hydroxybutan-2-yl-[(4-methylphenyl)sulfenyl]carba-
mate (6a). To a cooled solution of 4a (0.93 g, 2.1 mmol,
1 equiv) in 30 mL of dry acetonitrile, sym-collidine
(0.83 mL, 6.3 mmol, 3 equiv) and trifluoroacetic anhydride
(1.48 mL, 10.5 mmol, 5 equiv) were added. The solution
was allowed to reach room temperature and stirred for
48 h. Then 50 mL of 10% NaHCO3 was added and the re-
sulting mixture was vigorously stirred for 48 h. After the ad-
dition of water (50 mL), the mixture was extracted with Et2O
(4ꢂ50 mL). The organic phase was separated, washed with
5% HCl (50 mL), saturated NaHCO3 (2ꢂ50 mL), brine
(50 mL), dried, and concentrated. The residue was purified
by column chromatography eluting with hexane–ethyl ace-
tate 9:1 to produce 0.80 g (86%) of 6a as a colorless oil;
[a]D ꢀ51.6 (c 1.0, CHCl3); IR (CHCl3) nmax: 3485, 2929,
2857, 1700, 1679, 1460, 1368, 1299, 1163 cmꢀ1; 1H NMR
(CDCl3, 300 MHz): d 0.08 (s, 3H), 0.09 (s, 3H), 0.90 (s,
9H), 1.21 (d, 3H, J 6.8), 1.48 (s, 9H), 2.32 (s, 3H), 3.43
(br d, 2H, J 2.3), 3.69 (td, 1H, J 2.7 and 8.7), 4.49 (qd, 1H,
J 6.8 and 8.7), 7.11 and 7.19 (AA0BB0 system, 4H); 13C
NMR (CDCl3, 75 MHz): d ꢀ4.6, ꢀ4.3, 15.9, 18.1, 21.0,
25.9, 28.1, 56.5, 63.3, 74.4, 82.3, 126.1, 129.5, 136.2,
136.8, 157.6; EIMS m/z 442 (3%, M++1), 441 (2), 386 (6),
368 (6), 328 (54), 284 (43), 166 (100), 123 (34), 57 (33).
Anal. Calcd for C22H39NO4SSi: C, 59.82; H, 8.90; N,
3.17. Found: C, 59.99; H, 8.97; N, 3.22.
1671, 1469, 1368, 1311, 1162 cmꢀ1 1H NMR (CDCl3,
;
300 MHz): d 0.08 (s, 3H), 0.11 (s, 3H), 0.93 (s, 9H), 1.24
(d, 3H, J 6.9), 1.42 (s, 9H), 2.31 (s, 3H), 3.36 (dd, 1H, J
7.5 and 11.9), 3.49 (dd, 1H, J 4.2 and 11.9) 3.74 (dt, 1H, J
4.1 and 7.6), 4.69 (dq, 1H, J 4.1 and 6.9), 7.08 (A2B2 system,
4H); 13C NMR (CDCl3, 75 MHz): d ꢀ4.8, ꢀ4.4, 15.8, 18.0,
21.0, 25.8, 28.0, 54.8, 63.1, 75.5, 82.2, 124.0, 129.3, 135.6,
137.4, 158.4. Anal. Calcd for C22H39NO4SSi: C, 59.82; H,
8.90; N, 3.17. Found: C, 59.72; H, 8.65; N, 3.28.
3.1.8. (2S,3S) tert-Butyl-3-(tert-butyldimethylsilyloxy)-4-
oxobutan-2-yl-[(4-methylphenyl)sulfenyl]carbamate
(8a). To a solution of 6a (0.441 g, 1 mmol, 1 equiv) in 15 mL
of CH2Cl2, freshly prepared pyridinium chlorochromate
(0.323 g, 1.5 mmol, 1.5 equiv) was added. The mixture
was stirred at room temperature for 30 h. After filtration
the solvent was removed under vacuum. The product was
purified by column chromatography (hexane–ethyl acetate
95:5) to produce 0.337 g (77%) of 8a as colorless oil; [a]D
ꢀ43.4 (c 0.5, CHCl3); IR (film) nmax: 2932, 2859, 1733,
1701, 1468, 1368, 1298, 1163 cmꢀ1 1H NMR (CDCl3,
;
300 MHz): d 0.05 (s, 3H), 0.08 (s, 3H), 0.92 (s, 9H), 1.21
(d, 3H, J 6.7), 1.45 (s, 9H), 2.31 (s, 3H), 4.00 (dd, 1H, J
2.3 and 6.7), 4.66 (qd, 1H, J 6.7 and 6.7), 7.13 (A2B2 system,
4H), 9.55 (d, 1H, J 2.3); 13C NMR (CDCl3, 75 MHz):
d ꢀ5.0, ꢀ4.7, 14.7, 18.1, 21.0, 25.7, 28.0, 57.8, 79.2, 82.2,
125.2, 129.5, 136.4 (2C), 156.7, 202.1; EIMS m/z 439
(1%, M+), 384 (5), 326 (15), 298 (14), 166 (100), 123
3.1.6. (2S,3S) tert-Butyl-2-(tert-butyldimethylsilyloxy)-1-
hydroxy-5-methylhexan-3-yl-[(4-methylphenyl)sulfenyl]-
carbamate (6b). To a cooled solution of 4b (1.164 g,
2.4 mmol, 1 equiv) in 120 mL of dry acetonitrile, sym-
collidine (3 mL, 22.7 mmol, 9.5 equiv) and trifluoroacetic